FAS and neoplasm: Irradiation has been shown in various preclinical studies to alter tumor immune phenotype by augmenting the presence of MHC I on the tumor cell surface, improving expression of cancer-testis antigens and upregulating the FAS/CD95 complex [26, 32–35].